Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial

INTRODUCTION: Using data from the ertugliflozin cardiovascular outcomes trial in patients with type 2 diabetes mellitus (VERTIS CV; NCT01986881), associations between the initial estimated glomerular filtration rate (eGFR) “dip” with eGFR slope, glucosuria/natriuresis-related measures, and safety we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherney, David Z.I., Cosentino, Francesco, Dagogo-Jack, Samuel, McGuire, Darren K., Pratley, Richard E., Frederich, Robert, Maldonado, Mario, Liu, Chih-Chin, Pong, Annpey, Cannon, Christopher P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Patient-Oriented, Translational Research: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501765/
https://www.ncbi.nlm.nih.gov/pubmed/35691283
http://dx.doi.org/10.1159/000524889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501765/
https://www.ncbi.nlm.nih.gov/pubmed/35691283
http://dx.doi.org/10.1159/000524889

Ejemplares similares